Koyfin Home > Directory > Health Care > Abiomed Inc > Cash from Investing Activities

Abiomed Inc Cash from Investing Activities Chart (ABMD)

Abiomed Inc annual/quarterly Cash from Investing Activities from 2010 to 2020.
  • Abiomed Inc Cash from Investing Activities for the quarter ending September 09, 2020 was $-95m a -2.46% increase of 2m year over year
  • Abiomed Inc Cash from Investing Activities for the last 12 months ending September 09, 2020 was $-169m a -1.43% increase of 2m year over year
  • Abiomed Inc Annual Cash from Investing Activities for 2020 was $-125m a 7.17% decrease of -9m from 2019
  • Abiomed Inc Annual Cash from Investing Activities for 2019 was $-116m a -55.22% increase of 64m from 2018
  • Abiomed Inc Annual Cash from Investing Activities for 2018 was $-181m a 30.11% decrease of -54m from 2017
Other Cash Flow Metrics:
  • Abiomed Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $61m a 6.38% increase of 4m year over year
  • Abiomed Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $30m a 50.21% increase of 15m year over year
  • Abiomed Inc Total Revenue for the quarter ending December 12, 2018 was $201m a 13.03% increase of 26m year over year
View Chart On Koyfin

Quarterly ABMD Cash from Investing Activities Data

09/2020$-95m
06/2020$14m
03/2020$10m
12/2019$-97m
09/2019$8m
06/2019$-46m
03/2019$-36m
12/2018$-66m
09/2018$-50m
06/2018$35m

Annual ABMD Cash from Investing Activities Data

2020$-125m
2019$-116m
2018$-181m
2017$-126m
2016$-58m
2015$-50m
2014$-22m
2013$-10m
2012$-17m
2011$-2m